IPP Bureau
Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence
By IPP Bureau - November 28, 2025
Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd
Apollo Pharmacy becomes 7,000-store strong
By IPP Bureau - November 28, 2025
The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh
Medanta launches 550-bed super speciality hospital in Noida
By IPP Bureau - November 28, 2025
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
Piramal Pharma Solutions achieves global nitrosamine compliance, strengthening patient safety
By IPP Bureau - November 28, 2025
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
Renalys Pharma reports major phase III success for Sparsentan in Japanese IgA nephropathy patients
By IPP Bureau - November 28, 2025
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Exyte completes Pharmaplan integration
By IPP Bureau - November 28, 2025
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
GV20 Therapeutics hits milestone in AI-driven cancer therapy collaboration with Mitsubishi Tanabe Pharma
By IPP Bureau - November 28, 2025
GV20 received an upfront payment and is eligible for additional milestone payments
Ovation.io and PrecisionLife team to develop drug-response biomarkers for GLP-1 therapies
By IPP Bureau - November 28, 2025
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
Transmural Systems wins breakthrough FDA nod for coronary-saving TAVR device
By IPP Bureau - November 27, 2025
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
Investors pile in as Cordance secures oversubscribed seed round for brain-cancer tech
By IPP Bureau - November 27, 2025
The fresh capital will propel Cordance into its first-in-human clinical trial
Glenmark launches world’s first nebulized triple therapy for COPD
By IPP Bureau - November 27, 2025
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
India’s pharma industry showcases innovation, global ambitions at CPHI & PMEC India 2025
By IPP Bureau - November 27, 2025
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Novo Nordisk fast-tracks higher-dose obesity drug to FDA
By IPP Bureau - November 27, 2025
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
Lords Mark bets big on AI-driven dialysis tech, buys 85% stake in Renalyx Health
By IPP Bureau - November 27, 2025
Renalyx will continue operating as an independent unit within the group
Dr. Lal PathLabs launches India's first complement testing lab
By IPP Bureau - November 27, 2025
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
